hiv infection
Showing 26 - 50 of 554
Anal Carcinoma, HIV Infection, Human Papillomavirus Infection Trial in Los Angeles, Palm Springs (Cytology Specimen Collection
Active, not recruiting
- Anal Carcinoma
- +2 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Los Angeles, California
- +2 more
Sep 27, 2022
HIV Infection Trial in United States (N-803 (IL-15 Superagonist), VRC07-523LS, 10-1074)
Recruiting
- HIV Infection
- N-803 (IL-15 Superagonist)
- +2 more
-
Los Angeles, California
- +11 more
Sep 22, 2022
Immune Activation and Cardiovascular Risk in HIV
Active, not recruiting
- HIV Infection
- +2 more
- buprenorphine/naloxone
- +3 more
-
Cleveland, Ohio
- +1 more
Sep 20, 2022
Inflammation, HIV Infection, Cardiovascular Disease Trial in San Francisco (VB-201, Placebo)
Withdrawn
- Inflammation
- +2 more
- VB-201
- Placebo
-
San Francisco, CaliforniaZuckerberg San Francisco General Hospital
Sep 12, 2022
HIV Infection Trial in Worldwide (DOR/ISL, BIC/FTC/TAF, Placebo to BIC/FTC/TAF)
HCV Care and Treatment for HIV-HCV Co-infected Decentralised
Not yet recruiting
- HIV Infection
- Hepatitis C Infection
- Blood samples
-
Vinh, Nghe An, Vietnam
- +1 more
Aug 16, 2022
HIV Infection, Alcohol Consumption, Falls, Accidental Trial in Boston (Fall Prevention Intervention)
Completed
- HIV Infection
- +3 more
- Fall Prevention Intervention
-
Boston, MassachusettsBoston University Medical Campus
Aug 16, 2022
HIV Infection, HIV-associated Hodgkin Lymphoma, Stage III Adult Hodgkin Lymphoma Trial in France (brentuximab vedotin,
Active, not recruiting
- HIV Infection
- +3 more
- brentuximab vedotin
- +3 more
-
Clamart, France
- +5 more
Aug 11, 2022
AIDS-Related Kaposi Sarcoma, HIV Infection, Kaposi Sarcoma Trial in San Francisco, Bethesda, Seattle (Efineptakin alfa)
Recruiting
- AIDS-Related Kaposi Sarcoma
- +2 more
- Efineptakin alfa
-
San Francisco, California
- +2 more
Aug 9, 2022
AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United
Recruiting
- AIDS-Related Non-Hodgkin Lymphoma
- +29 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Birmingham, Alabama
- +12 more
Aug 4, 2022
HIV Infection Trial in Italy, Netherlands, Spain (Analytical Treatment Interruption + bNAbs infusion)
Withdrawn
- HIV Infection
- Analytical Treatment Interruption + bNAbs infusion
-
Milan, Lombardy, Italy
- +3 more
Aug 2, 2022
AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma Trial run by the
Active, not recruiting
- AIDS-Related Burkitt Lymphoma
- +5 more
- Prednisone
- +7 more
-
Bethesda, MarylandNCI Lymphoid Malignancies Branch
Jul 31, 2022
AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in France, United
Active, not recruiting
- AIDS-Related Hodgkin Lymphoma
- +11 more
- Brentuximab Vedotin
- +4 more
-
La Jolla, California
- +27 more
Jul 27, 2022
HIV Infection, Drug Use Trial in St. Petersburg (other, drug, behavioral)
Completed
- HIV Infection
- Drug Use
- Rapid ART initiation
- +2 more
-
St. Petersburg, Russian Federation
- +1 more
Jul 26, 2022
HIV Infection Trial in Badalona (ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).,
Recruiting
- HIV Infection
- ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).
- Normal saline solution
-
Badalona, Barcelona, SpainGermans Trias i Pujol Hospital
Jul 11, 2022
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Withdrawn
- Cervical Adenocarcinoma
- +6 more
- Carboplatin
- +4 more
-
Cape Town, South Africa
- +2 more
Jun 14, 2022
Drug-Drug Interaction, HIV Infection Trial in Masafu, Kampala (Dihydroartemisinin-piperaquine)
Completed
- Drug-Drug Interaction
- HIV Infection
-
Masafu, Busia, Uganda
- +1 more
May 18, 2022
HIV Infection Trial in Worldwide (Analytical Treatment Interruption)
Recruiting
- HIV Infection
- Analytical Treatment Interruption
-
Gaborone, Botswana
- +10 more
May 16, 2022
HIV+ Deceased Donor Transplant for HIV+ Recipients
Recruiting
- HIV Infection
- HIV-infected deceased donor organ
-
Aurora, Colorado
- +17 more
May 4, 2022
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
HIV Infection Trial in Lima (ART initiation at time of HIV diagnosis, ART at 24 weeks)
Completed
- HIV Infection
- ART initiation at time of HIV diagnosis
- ART at 24 weeks
-
Lima, PeruAsociación Civil Impacta Salud y Educación
Mar 2, 2022
AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I DLBCL Trial in United States
Completed
- AIDS-Related Plasmablastic Lymphoma
- +15 more
- Cyclophosphamide
- +8 more
-
Montgomery, Alabama
- +34 more
Feb 23, 2022
Access to Rights, Catch-up Vaccination, Treatment of Conditions
Recruiting
- HIV Infection
-
Montreuil, FrancePauline Penot
Feb 25, 2022
Hepatitis C in HIV Infected Injection Drug Users (IDUs)
Completed
- HIV Infection
- Hepatitis C
-
Baltimore, MarylandJohns Hopkins Hospital
Feb 17, 2022
AIDS-related Non-Hodgkin Lymphoma, AIDS-related Plasmablastic Lymphoma, AIDS-related Primary Effusion Lymphoma Trial in Duarte
Active, not recruiting
- AIDS-related Non-Hodgkin Lymphoma
- +3 more
- busulfan
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022